| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.057 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |